Table: Cytori Cell Research Institute -2023/24 group results

ADR Biomedical Holdings

14/05/2024 08:30

May 14 (Reuters)- 
          Cytori Cell Research Institute, Inc. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended       Year ended       Year to       NEXT   
                Mar 31, 2024     Mar 31, 2023   Mar 31, 2025     YEAR     
                   LATEST          YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS        FORECAST    H1 FORECAST 
  Sales             1.56             2.14           1.28                  
                 (-27.2 pct)     (+60.6 pct)     (-17.7 pct)              
  Operating     loss 772 mln     loss 794 mln    loss 84 mln              
  Recurring     loss 906 mln     loss 862 mln    loss 87 mln              
  Net
  Net              138 mln        loss 1.06        103 mln                
                                                 (-25.4 pct)              
  EPS             15.47 yen    loss 118.71 yen    11.54 yen               
  EPS Diluted     15.42 yen                                               
  Ann Div            NIL             NIL                                  
  -Q2 Div            NIL             NIL                                  
  -Q4 Div            NIL             NIL                                  
  
  NOTE - Cytori Cell Research Institute, Inc..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3750.T